MedPath

the Application of Exhaled breath aNalysis in the Early detection of ASpergillosis

Conditions
Invasive aspergillosis
Registration Number
NL-OMON28185
Lead Sponsor
one.
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Not specified
Target Recruitment
20
Inclusion Criteria

Patients, aged 18 or older, that will undergo treatment for a hematological malignancy expected to result in grade 4 neutropenia for more than 7 days, e.g. hematopoietic stem cell transplantation or induction/consolidation treatment for acute myeloid leukaemia.

Exclusion Criteria

Previous invasive pulmonary mycosis.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The accuracy with which patients with probable or proven invasive pulmonary aspergillosis and neutropenic controls can be discriminated from each other with exhaled breath analysis using among other techniques GC-MS, as measured by the values of the sensitivity, specificity and accuracy.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath